SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-051279
Filing Date
2020-11-05
Accepted
2020-11-05 16:01:57
Documents
74
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q spro-10q_20200930.htm   iXBRL 10-Q 3698677
2 EX-31.1 spro-ex311_11.htm EX-31.1 22406
3 EX-31.2 spro-ex312_12.htm EX-31.2 22323
4 EX-32.1 spro-ex321_9.htm EX-32.1 9830
5 EX-32.2 spro-ex322_10.htm EX-32.2 9840
  Complete submission text file 0001564590-20-051279.txt   11756621

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA spro-20200930.xsd EX-101.SCH 79836
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE spro-20200930_cal.xml EX-101.CAL 52622
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE spro-20200930_def.xml EX-101.DEF 275842
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE spro-20200930_lab.xml EX-101.LAB 563467
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE spro-20200930_pre.xml EX-101.PRE 442271
11 EXTRACTED XBRL INSTANCE DOCUMENT spro-10q_20200930_htm.xml XML 2128070
Mailing Address 675 MASSACHUSETTS AVENUE 14TH FLOOR CAMBRIDGE MA 02139
Business Address 675 MASSACHUSETTS AVENUE 14TH FLOOR CAMBRIDGE MA 02139 857-242-1600
Spero Therapeutics, Inc. (Filer) CIK: 0001701108 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38266 | Film No.: 201290319
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences